Squalene based nanocomposites: A new platform for the design of multifunctional pharmaceutical theragnostics

ACS Nano

Volumn 5, Issue 2, 2011, Pages 1513-1521

  Arias, José L ^a   Reddy, L Harivardhan ^b,d   Othman, Mohammad ^b   Gillet, Brigitte ^b,e   Desmaële, Didier ^b   Zouhiri, Fatima ^b   Dosio, Franco ^c   Gref, Ruxandra ^b   Couvreur, Patrick ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY OF TURIN   (Italy)

^d SANOFI   (France)

^e INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

Author keywords

cancer therapy; drug delivery system; magnetic resonance imaging; squalenoyl prodrug; theragnostic nanomedicine; ultrasmall superparamagnetic iron oxide

Indexed keywords

CONTROLLED DRUG DELIVERY; DIAGNOSIS; DISEASES; DRUG PRODUCTS; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; MAGNETISM; MAGNETITE; MAGNETITE NANOPARTICLES; MEDICAL NANOTECHNOLOGY; NANOCOMPOSITES; NANOCRYSTALS; ONCOLOGY; TUMORS;

ANTICANCER ACTIVITIES; CANCER THERAPY; CONCEPTUAL FRAMEWORKS; DRUG DELIVERY SYSTEM; MAGNETIC RESONANCE IMAGING (MRI); PRODRUGS; SELF ASSEMBLING MOLECULES; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

TARGETED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; MAGNETITE NANOPARTICLE; NANOCOMPOSITE; PRODRUG; SQUALENE;

ANIMAL; ARTICLE; CHEMICAL PHENOMENA; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; MAGNETISM; METABOLISM; METHODOLOGY; MOUSE; NANOMEDICINE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; DEOXYCYTIDINE; DRUG DELIVERY SYSTEMS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MAGNETITE NANOPARTICLES; MICE; NANOCOMPOSITES; NANOMEDICINE; NEOPLASMS; PRODRUGS; SQUALENE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79951933087     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn1034197     Document Type: Article

References (33)

1. Official Web site of the American Cancer Society (http://www.cancer.org/ docroot/PRO/content/PRO-1-1-Cancer-Statistics-2009-Presentation.asp, accessed December 10, 2010).
2. Official Web site of the Institut National d'Etudes Démographiques (http://www.ined.fr, accessed December 10, 2010).
3. Torchilin, V. P. Multifunctional Nanocarriers Adv. Drug Delivery Rev. 2006, 58, 1532-1555 (Pubitemid 44822608)
4. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis Adv. Drug Delivery Rev. 2002, 54, 631-651 (Pubitemid 35247520)
5. Zamboni, W. C. Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents Oncologist 2008, 13, 248-260 (Pubitemid 351679900)
6. Zhang, L.; Gu, F. X.; Chan, J. M.; Wang, A. Z.; Langer, R. S.; Farokhzad, O. C. Nanoparticles in Medicine: Therapeutic Applications and Developments Clin. Pharmacol. Ther. 2008, 83, 761-769 (Pubitemid 351556021)
7. Barraud, L.; Merle, P.; Soma, E.; Lefrançois, L.; Guerret, S.; Chevallier, M.; Dubernet, C.; Couvreur, P.; Trépo, C.; Vitvitski, L. Increase of Doxorubicin Sensitivity by Doxorubicin-Loading into Nanoparticles for Hepatocellular Carcinoma Cells in Vitro and in Vivo J. Hepatol. 2005, 42, 736-743
8. Moog, R.; Burger, A. M.; Brandl, M.; Schüler, J.; Schubert, R.; Unger, C.; Fiebig, H. H.; Massing, U. Change in Pharmacokinetic and Pharmacodynamic Behaviour of Gemcitabine in Human Tumor Xenografts upon Entrapment in Vesicular Phospholipid Gels Cancer Chemother. Pharmacol. 2002, 49, 356-366 (Pubitemid 34439336)
9. Yang, J.; Park, S. B.; Yoon, H. G.; Huh, Y. M.; Haam, S. Preparation of Poly ε-Caprolactone Nanoparticles Containing Magnetite for Magnetic Drug Carrier Int. J. Pharm. 2006, 324, 185-190 (Pubitemid 44528914)
10. Jiang, B.; Hu, L.; Gao, C.; Shen, J. Ibuprofen-Loaded Nanoparticles Prepared by a Co-precipitation Method and Their Release Properties Int. J. Pharm. 2005, 304, 220-230 (Pubitemid 41427664)
11. Esmaeilia, F.; Dinarvand, R.; Ghahremani, M. H.; Ostad, S. N.; Esmaily, H.; Atyabi, F. Cellular Cytotoxicity and in Vivo Biodistribution of Docetaxel Poly(lactide- co -glycolide) Nanoparticles Anticancer Drugs 2010, 21, 43-52
12. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Elst, L. V.; Muller, R. N. Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications Chem. Rev. 2008, 108, 2064-2110
13. Shubayev, V. I.; Pisanic, T. R., 2nd; Jin, S. Magnetic Nanoparticles for Theragnostics Adv. Drug Delivery Rev. 2009, 61, 467-477
14. 4 and Gemcitabine Enhance Anti-Tumor Effect in Pancreatic Cancer Xenograft Mouse Model J. Drug Target 2007, 15, 445-453 (Pubitemid 47073060)
15. 4-Loaded Polymeric Micelles for Dual Targeting of Cancer Cells Polymer 2008, 49, 3477-3485
16. Lin, J. J.; Chen, J. S.; Huang, S. J.; Ko, J. H.; Wang, Y. M.; Chen, T. L.; Wang, L. F. Folic Acid-Pluronic F127 Magnetic Nanoparticle Clusters for Combined Targeting, Diagnosis, and Therapy Applications Biomaterials 2009, 30, 5114-5124
17. McCarthy, J. R.; Jaffer, F. A.; Weissleder, R. A Macrophage-Targeted Theranostic Nanoparticle for Biomedical Applications Small 2006, 2, 983-987 (Pubitemid 44230996)
18. Hong, G.; Yuan, R.; Liang, B.; Shen, J.; Yang, X.; Shuai, X. Folate-Functionalized Polymeric Micelle as Hepatic Carcinoma-Targeted, MRI-Ultrasensitive Delivery System of Antitumor Drugs Biomed. Microdevices 2008, 10, 693-700
19. Nasongkla, N.; Bey, E.; Ren, J.; Ai, H.; Khemtong, C.; Guthi, J. S.; Chin, S. F.; Sherry, A. D.; Boothman, D. A.; Gao, J. Multifunctional Polymeric Micelles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems Nano Lett. 2006, 6, 2427-2430 (Pubitemid 46076928)
20. Pan, D.; Caruthers, S. D.; Hu, G.; Senpan, A.; Scott, M. J.; Gaffney, P. J.; Wickline, S. A.; Lanza, G. M. Ligand-Directed Nanobialys as Theranostic Agent for Drug Delivery and Manganese-Based Magnetic Resonance Imaging of Vascular Targets J. Am. Chem. Soc. 2008, 130, 9186-9187 (Pubitemid 352031102)
21. Jain, T. K.; Foy, S. P.; Erokwu, B.; Dimitrijevic, S.; Flask, C. A.; Labhasetwar, V. Magnetic Resonance Imaging of Multifunctional Pluronic Stabilized Iron-Oxide Nanoparticles in Tumor-Bearing Mice Biomaterials 2009, 30, 6748-6756
22. Santra, S.; Kaittanis, C.; Grimm, J.; Perez, J. M. Drug/Dye-Loaded, Multifunctional Iron Oxide Nanoparticles for Combined Targeted Cancer Therapy and Dual Optical/Magnetic Resonance Imaging Small 2009, 5, 1862-1868
23. Couvreur, P.; Stella, B.; Reddy, L. H.; Hillaireau, H.; Dubernet, C.; Desmaële, D.; Lepêtre-Mouelhi, S.; Rocco, F.; Dereuddre-Bosquet, N.; Clayette, P.; et al. Squalenoyl Nanomedicines as Potential Therapeutics Nano Lett. 2006, 6, 2544-2548 (Pubitemid 46076946)
24. Reddy, L. H.; Khoury, H.; Paci, A.; Deroussent, A.; Ferreira, H.; Dubernet, C.; Declèves, X.; Besnard, M.; Chacun, H.; Lepêtre- Mouelhi, S.; et al. Squalenoylation Favorably Modifies the in Vivo Pharmacokinetics and Biodistribution of Gemcitabine in Mice Drug Metab. Dispos. 2008, 36, 1570-1577
25. Bildstein, L.; Dubernet, C.; Marsaud, V.; Chacun, H.; Nicolas, V.; Gueutin, C.; Sarasin, A.; Benech, H.; Lepetre-Mouelhi, S.; Desmaële, D.; Couvreur, P. Transmembrane Diffusion of Gemcitabine by a Nanoparticulate Squalenoyl Prodrug: An Original Drug Delivery Pathway J. Controlled Release 2010, 147, 163-170
26. Kastsler, B.; Vetter, D. Comprendre l'IRM, 6 th ed.; Elsevier Masson S.A.S.: Issy-les Moulineaux, 2006.
27. Reddy, L. H.; Renoir, J. M.; Marsaud, V.; Lepetre-Mouelhi, S.; Desmaële, D.; Couvreur, P. Anticancer Efficacy of Squalenoyl Gemcitabine Nanomedicine on 60 Human Tumor Cell Panel and on Experimental Tumor Mol. Pharm. 2009, 6, 1526-1535
28. Nicolle, G. M.; Tóth, É.; Eisenwiener, K. P.; Mäcke, H. R.; Merbach, A. E. From Monomers to Micelles: Investigation of the Parameters Influencing Proton Relaxivity J. Biol. Inorg. Chem. 2002, 7, 757-769 (Pubitemid 36056360)
29. Accardo, A.; Tesauro, D.; Morelli, G.; Gianolio, E.; Aime, S.; Vaccaro, M.; Mangiapia, G.; Paduano, L.; Schillén, K. High-Relaxivity Supramolecular Aggregates Containing Peptides and Gd Complexes as Contrast Agents in MRI J. Biol. Inorg. Chem. 2007, 12, 267-276 (Pubitemid 46197950)
30. Oliver, M.; Ahmad, A.; Kamaly, N.; Perouzel, E.; Caussin, A.; Keller, M.; Herlihy, A.; Bell, J.; Miller, A. D.; Jorgensen, M. R. MAGfect: A Novel Liposome Formulation for MRI Labelling and Visualization of Cells Org. Biomol. Chem. 2006, 4, 3489-3497 (Pubitemid 44319637)
31. Couvreur, P.; Reddy, L. H.; Mangenot, S.; Poupaert, J. H.; Desmaële, D.; Lepêtre-Mouelhi, S.; Pili, B.; Bourgaux, C.; Amenitsch, H.; Ollivon, M. Discovery of New Hexagonal Supramolecular Nanostructures Formed by Squalenoylation of an Anticancer Nucleoside Analogue Small 2008, 4, 247-253 (Pubitemid 351271158)
32. Szebeni, J.; Moghimi, S. M. Liposome Triggering of Innate Immune Responses: A Perspective on Benefits and Adverse Reactions J. Liposome Res. 2009, 19, 85-90
33. Massart, R. Preparation of Aqueous Magnetic Liquids in Alkaline and Acidic Media IEEE Trans. Magn. 1981, 17, 1247-1248 (Pubitemid 11497282)